查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478628

穿戴式註射器市场,占有率,规模,趋势,行业分析报告:依类型,技术,适应症,最终用途,地区,细分市场预测2024-2032 年

Wearable Injectors Market Share, Size, Trends, Industry Analysis Report, By Type (Off-body, On-body); By Technology; By Indication; By End Use; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球穿戴式注射器市场规模预计将达到 188.7 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

穿戴式注射器市场是由全球医疗基础设施的进步所推动的。医院、诊所和家庭护理场所的设备改进将有助于将穿戴式註射器技术整合到医疗保健系统中，并改善患者护理的提供。远距医疗和远端监控的投资将进一步支持穿戴式註射器的使用并实现远距患者管理。此外，改善的医疗基础设施将改善医疗服务的可近性，并提高病患对穿戴式註射器的认识和接受度。随着医疗保健系统满足人口老化和慢性病增加的需求，穿戴式註射器正在成为一种便利的药物管理解决方案。

穿戴式注射器市场也受到全球医疗保健系统日益重视以病人为中心的照护的影响。这种个人化的治疗方法优先考虑患者的便利性、舒适性和自主性。穿戴式注射器允许患者在临床环境之外自行给药，使他们能够更好地控制自己的医疗保健。透过提供连续的药物传递和精确的剂量，这些设备可确保最佳的治疗效果。穿戴式注射器让患者在家中或外出时接受治疗，提高患者满意度和治疗依从性，同时降低与医院就诊相关的医疗费用。

随着穿戴式装置在日常生活中的普及，将穿戴式解决方案纳入医疗保健领域越来越被接受。穿戴式注射器提供方便、精确的药物输送，无缝地适应了这一趋势。患者习惯使用穿戴式装置进行健康监测，这使得他们更容易接受穿戴式注射器技术。穿戴式科技的进步，例如增强的感测器和连接功能，将改善穿戴式注射器的功能。与数位健康平台整合可以实现无缝数据收集和分析，以实现个人化医疗干预。

新兴地区的市场扩张为穿戴式注射器市场带来了巨大机会。由于经济发展和医疗保健机会的改善，对先进医疗技术的需求不断增加。穿戴式注射器为给药提供了一种便捷的方法，并满足新兴市场医疗保健系统的需求。慢性病的流行和医疗费用的上涨等因素正在推动其采用。本地供应商和全球製造商之间的合作将加速技术的采用。

穿戴式注射器市场报告亮点

到 2023 年，由于便利性、易用性和可客製化设计的提高，贴装市场占据了很大的收入占有率。

到 2023 年，由于可靠的药物输送、紧凑的设计和成本效益，弹簧加载细分市场占据了主要的收入占有率。

2023年，由于疾病负担高、治疗方案复杂以及治疗依从性提高，肿瘤学占了很大的销售占有率。

2023 年，由于工作流程简化、治疗依从性提高以及监管合规性提高，医院和诊所部门在销售额中占据很大占有率。

由于医疗保健支出增加、人口老化加剧和政府举措，预计亚太地区在预测期内将显着增长。

市场遍布全球，包括 Amgen Inc.、Becton、Dickinson and Company、CeQur SA、Medtronic plc、Roche Diagnostics International Ltd.、United Therapeutics Corporation、West Pharmaceutical Services, Inc. 和 Ypsomed Holding AG。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球穿戴式注射器市场洞察

  • 穿戴式注射器 - 业界快照
  • 穿戴式注射器市场动态
    • 驱动因素和机遇
      • 由于慢性病盛行率的增加，预计对该产品的需求将会增加。
      • 人口老化的加剧预计将推动穿戴式注射器市场的成长
    • 限制因素和课题
      • 开发成本高
  • PESTLE分析
  • 穿戴式注射器产业趋势
  • 价值链分析
  • COVID-19 影响分析

第五章全球穿戴式注射器市场：依科技分类

  • 主要发现
  • 介绍
  • 迴转泵
  • 弹簧底座
  • 扩充电池
  • 马达驱动
  • 其他

第六章全球穿戴式注射器市场：依类型

  • 主要发现
  • 介绍
  • 离开身体
  • 在身体上

第七章全球穿戴式注射器市场：依迹象分类

  • 主要发现
  • 介绍
  • 心血管疾病
  • 肿瘤学
  • 免疫缺陷
  • 感染
  • 自身免疫性疾病
  • 其他

第八章全球穿戴式注射器市场：依最终用途分类

  • 主要发现
  • 介绍
  • 医院和诊所
  • 居家护理
  • 其他

第九章全球穿戴式注射器市场：依地区

  • 主要发现
  • 介绍
    • 穿戴式注射器市场评估：依地区，2019-2032
  • 北美
    • 北美：依技术划分，2019-2032
    • 北美：依最终用途分类，2019-2032
    • 北美：依类型划分，2019-2032
    • 北美：依迹象显示，2019-2032
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依技术分类，2019-2032
    • 欧洲：依最终用途分类，2019-2032
    • 欧洲：依类型划分，2019-2032
    • 欧洲：依症状分类，2019-2032
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依技术分类，2019-2032
    • 亚太地区：依最终用途分类，2019-2032
    • 亚太地区：依类型划分，2019-2032
    • 亚太地区：依指标划分，2019-2032
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印度尼西亚
    • 韩国
  • 中东/非洲
    • 中东和非洲：依技术分类，2019-2032
    • 中东和非洲：依最终用途分类，2019-2032
    • 中东和非洲：依类型划分，2019-2032
    • 中东和非洲：依指标划分，2019-2032
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯联合酋长国
  • 拉丁美洲
    • 拉丁美洲：依技术分类，2019-2032
    • 拉丁美洲：依最终用途分类，2019-2032
    • 拉丁美洲：依类型划分，2019-2032
    • 拉丁美洲：依指标划分，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第十一章公司简介

  • Amgen Inc
  • Becton, Dickinson and Company
  • CeQur SA
  • Debiotech SA
  • Elcam Medical
  • Enable Injections
  • Insulet Corporation
  • Medtronic plc
  • Roche Diagnostics International Ltd.
  • Sorrel Medical
  • Tandem Diabetes Care, Inc.
  • Unilife Corporation
  • United Therapeutics Corporation
  • West Pharmaceutical Services, Inc
  • Ypsomed Holding AG
Product Code: PM4842

The global Wearable Injectors market size is expected to reach USD 18.87 billion by 2032, according to a new study by Polaris Market Research. The report "Wearable Injectors Market Share, Size, Trends, Industry Analysis Report, By Type (Off-body, On-body); By Technology; By Indication; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The wearable injectors market is fueled by advancements in healthcare infrastructure globally. Improved facilities in hospitals, clinics, and home care settings facilitate the integration of wearable injector technology into healthcare systems, enhancing patient care delivery. Investments in telemedicine and remote monitoring further support wearable injector usage, enabling remote patient management. Additionally, better healthcare infrastructure enhances access to healthcare services, increasing patient awareness and acceptance of wearable injector devices. As healthcare systems adapt to address the needs of aging populations and rising chronic diseases, wearable injectors emerge as a convenient solution for medication administration.

The wearable injectors market is also influenced by a growing emphasis on patient-centric care in healthcare systems worldwide. These personalized treatment approaches prioritize patient convenience, comfort, and autonomy. Wearable injectors empower patients to self-administer medications outside clinical settings, enhancing control over their health management. By providing continuous drug delivery and precise dosage administration, these devices ensure optimal therapeutic outcomes. With the ability to receive treatment at home or while on the move, wearable injectors improve patient satisfaction and treatment adherence while reducing healthcare costs associated with hospital visits.

With the increasing prevalence of wearable devices in daily life, there's growing acceptance of incorporating wearable solutions into healthcare. Wearable injectors, providing convenient and precise drug delivery, align seamlessly with this trend. Patients' familiarity with using wearable devices for health monitoring makes them more receptive to wearable injector technology. Advancements in wearable tech, like enhanced sensors and connectivity features, improve the functionality of wearable injectors. Integration with digital health platforms enables seamless data collection and analysis for personalized healthcare interventions.

Market expansion in emerging regions presents significant opportunities for the wearable injectors market. With economic development and improved healthcare access, demand for advanced medical technologies rises. Wearable injectors offer a convenient method for medication administration, aligning with the needs of healthcare systems in emerging markets. Factors such as increasing chronic disease prevalence and healthcare expenditure drive adoption. Collaborations between local providers and global manufacturers facilitate technology introduction.

Wearable Injectors Market Report Highlights

In 2023, the on-body segment held significant revenue share owing to enhanced convenience, ease of use, and customizable design.

In 2023, the spring-based segment held significant revenue share owing to reliable drug delivery, compact design, and cost-effectiveness.

In 2023, the oncology held significant revenue share owing to high disease burden, complex treatment regimens, and improved treatment adherence.

In 2023, the hospitals and clinics segment held significant revenue share owing to streamlined workflow, enhanced treatment adherence, and regulatory compliance.

Asia-Pacific region is expected to experience significant growth during the forecast period due to increasing healthcare expenditure, growing aging population, and government initiatives.

The market is highly competitive owing to the existence of market players with a global presence, including Amgen Inc., Becton, Dickinson and Company, CeQur SA, Medtronic plc, Roche Diagnostics International Ltd., United Therapeutics Corporation, West Pharmaceutical Services, Inc., and Ypsomed Holding AG among others.

Polaris Market Research has segmented the Wearable Injectors market report based on type, technology, indication, end use, and region:

Wearable Injectors, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Off-body
  • On-body

Wearable Injectors, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Rotary pump
  • Spring-based
  • Expanding battery
  • Motor-driven
  • Others

Wearable Injectors, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cardiovascular Diseases
  • Oncology
  • Immunodeficiency
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

Wearable Injectors, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals and Clinics
  • Home Care
  • Others

Wearable Injectors, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Wearable Injectors Market Insights

  • 4.1. Wearable Injectors - Industry Snapshot
  • 4.2. Wearable Injectors Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of chronic diseases is projected to spur the product demand
      • 4.2.1.2. Growing aging population is expected to drive wearable injectors market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of development
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Wearable Injectors Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Wearable Injectors Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. Rotary pump
    • 5.3.1. Global Wearable Injectors Market, by Rotary pump, by Region, 2019-2032 (USD Billion)
  • 5.4. Spring-based
    • 5.4.1. Global Wearable Injectors Market, by Spring-based, by Region, 2019-2032 (USD Billion)
  • 5.5. Expanding battery
    • 5.5.1. Global Wearable Injectors Market, by Expanding battery, by Region, 2019-2032 (USD Billion)
  • 5.6. Motor-driven
    • 5.6.1. Global Wearable Injectors Market, by Motor-driven, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Wearable Injectors Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Off-body
    • 6.3.1. Global Wearable Injectors Market, by Off-body, by Region, 2019-2032 (USD Billion)
  • 6.4. On-body
    • 6.4.1. Global Wearable Injectors Market, by On-body, by Region, 2019-2032 (USD Billion)

7. Global Wearable Injectors Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 7.3. Cardiovascular Diseases
    • 7.3.1. Global Wearable Injectors Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Billion)
  • 7.4. Oncology
    • 7.4.1. Global Wearable Injectors Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 7.5. Immunodeficiency
    • 7.5.1. Global Wearable Injectors Market, by Immunodeficiency, by Region, 2019-2032 (USD Billion)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Wearable Injectors Market, by Infectious Diseases, by Region, 2019-2032 (USD Billion)
  • 7.7. Autoimmune Diseases
    • 7.7.1. Global Wearable Injectors Market, by Autoimmune Diseases, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Wearable Injectors Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • 8.3. Hospitals and Clinics
    • 8.3.1. Global Wearable Injectors Market, by Hospitals and Clinics, by Region, 2019-2032 (USD Billion)
  • 8.4. Home Care
    • 8.4.1. Global Wearable Injectors Market, by Home Care, by Region, 2019-2032 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Wearable Injectors Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Wearable Injectors Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Wearable Injectors Market - North America
    • 9.3.1. North America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.5. Wearable Injectors Market - U.S.
      • 9.3.5.1. U.S.: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.6. Wearable Injectors Market - Canada
      • 9.3.6.1. Canada: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.4. Wearable Injectors Market - Europe
    • 9.4.1. Europe: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.5. Wearable Injectors Market - UK
      • 9.4.5.1. UK: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.6. Wearable Injectors Market - France
      • 9.4.6.1. France: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.7. Wearable Injectors Market - Germany
      • 9.4.7.1. Germany: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.8. Wearable Injectors Market - Italy
      • 9.4.8.1. Italy: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.9. Wearable Injectors Market - Spain
      • 9.4.9.1. Spain: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.10. Wearable Injectors Market - Netherlands
      • 9.4.10.1. Netherlands: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.11. Wearable Injectors Market - Russia
      • 9.4.11.1. Russia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.5. Wearable Injectors Market - Asia Pacific
    • 9.5.1. Asia Pacific: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.5. Wearable Injectors Market - China
      • 9.5.5.1. China: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.6. Wearable Injectors Market - India
      • 9.5.6.1. India: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.7. Wearable Injectors Market - Japan
      • 9.5.7.1. Japan: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.8. Wearable Injectors Market - Malaysia
      • 9.5.8.1. Malaysia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.9. Wearable Injectors Market - Indonesia
      • 9.5.9.1. Indonesia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.10. Wearable Injectors Market - South Korea
      • 9.5.10.1. South Korea: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.6. Wearable Injectors Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.5. Wearable Injectors Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.6. Wearable Injectors Market - South Africa
      • 9.6.6.1. South Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.7. Wearable Injectors Market - Israel
      • 9.6.7.1. Israel: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.8. Wearable Injectors Market - UAE
      • 9.6.8.1. UAE: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.7. Wearable Injectors Market - Latin America
    • 9.7.1. Latin America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.5. Wearable Injectors Market - Mexico
      • 9.7.5.1. Mexico: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.6. Wearable Injectors Market - Brazil
      • 9.7.6.1. Brazil: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.7. Wearable Injectors Market - Argentina
      • 9.7.7.1. Argentina: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Amgen Inc
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Becton, Dickinson and Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. CeQur SA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Debiotech SA
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Elcam Medical
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Enable Injections
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Insulet Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Medtronic plc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Roche Diagnostics International Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Sorrel Medical
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Tandem Diabetes Care, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Unilife Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. United Therapeutics Corporation
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. West Pharmaceutical Services, Inc
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Ypsomed Holding AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Wearable Injectors Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Wearable Injectors Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Wearable Injectors Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Wearable Injectors Market, by End Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Wearable Injectors Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 8 North America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 North America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 13 U.S.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 17 Canada: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 Europe: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Germany: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 France: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 28 France: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 29 France: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 30 UK: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 32 UK: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 UK: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 37 Italy: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Spain: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 49 Russia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 54 China: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 56 China: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 China: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 61 Japan: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 India: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 64 India: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 India: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 77 South Korea: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Latin America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Brazil: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 89 Mexico: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 93 Argentina: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 101 UAE: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 109 South Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 113 Israel: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Wearable Injectors Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Wearable Injectors Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Wearable Injectors Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Wearable Injectors Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Wearable Injectors Market, by Indication, 2021 & 2030 (USD Billion)